|
2024-07-29 |
2024-07-26 |
VP
Vente planifiée
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
4 312
-19.2%
91,15
393 039 USD
|
4 312
-19.2%
|
91,15
|
393 039 USD
|
|
|
2024-07-15 |
2024-07-12 |
VP
Vente planifiée
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
79
-0.4%
90,00
7 110 USD
|
79
-0.4%
|
90,00
|
7 110 USD
|
|
|
2024-07-15 |
2024-07-11 |
VP
Vente planifiée
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
2 136
-9.1%
90,00
192 240 USD
|
2 136
-9.1%
|
90,00
|
192 240 USD
|
|
|
2024-05-29 |
2024-05-29 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
4 094
-11.6%
88,57
362 606 USD
|
4 094
-11.6%
|
88,57
|
362 606 USD
|
|
|
2024-05-29 |
2024-05-29 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
8 896
-20.1%
87,86
781 603 USD
|
8 896
-20.1%
|
87,86
|
781 603 USD
|
|
|
2024-05-29 |
2024-05-29 |
VP
Vente planifiée
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
8 857
-32.7%
87,53
775 253 USD
|
8 857
-32.7%
|
87,53
|
775 253 USD
|
|
|
2024-05-21 |
2024-05-20 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
1 604
-4.9%
95,08
152 508 USD
|
1 604
-4.9%
|
95,08
|
152 508 USD
|
|
|
2024-05-21 |
2024-05-20 |
VP
Vente planifiée
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
987
-4.4%
95,08
93 844 USD
|
987
-4.4%
|
95,08
|
93 844 USD
|
|
|
2024-05-21 |
2024-05-20 |
VP
Vente planifiée
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
686
-3.6%
95,11
65 245 USD
|
686
-3.6%
|
95,11
|
65 245 USD
|
|
|
2024-05-21 |
2024-05-17 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
1 073
-3.5%
95,00
101 935 USD
|
1 073
-3.5%
|
95,00
|
101 935 USD
|
|
|
2024-05-21 |
2024-05-17 |
VP
Vente planifiée
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
822
-4.8%
94,82
77 942 USD
|
822
-4.8%
|
94,82
|
77 942 USD
|
|
|
2024-05-17 |
2024-05-16 |
VP
Vente planifiée
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
770
-4.3%
96,14
74 028 USD
|
770
-4.3%
|
96,14
|
74 028 USD
|
|
|
2024-05-17 |
2024-05-16 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
985
-3.1%
96,14
94 698 USD
|
985
-3.1%
|
96,14
|
94 698 USD
|
|
|
2024-05-17 |
2024-05-16 |
VP
Vente planifiée
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
733
-4.5%
96,04
70 397 USD
|
733
-4.5%
|
96,04
|
70 397 USD
|
|
|
2024-05-08 |
2024-05-06 |
VP
Vente planifiée
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
2 305
-15.8%
95,00
218 975 USD
|
2 305
-15.8%
|
95,00
|
218 975 USD
|
|
|
2023-09-13 |
2023-09-12 |
VP
Vente planifiée
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
228
-1.4%
90,65
20 668 USD
|
228
-1.4%
|
90,65
|
20 668 USD
|
|
|
2023-09-13 |
2023-09-11 |
VP
Vente planifiée
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
2 305
-13.7%
90,00
207 450 USD
|
2 305
-13.7%
|
90,00
|
207 450 USD
|
|
|
2023-09-07 |
2023-09-05 |
VP
Vente planifiée
|
Dockendorff Charles J
Administrateur non-exécutif
|
10 215
-82.1%
87,68
895 651 USD
|
10 215
-82.1%
|
87,68
|
895 651 USD
|
|
|
2023-07-20 |
2023-07-18 |
VP
Vente planifiée
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
4 928
-21.1%
90,00
443 520 USD
|
4 928
-21.1%
|
90,00
|
443 520 USD
|
|
|
2023-06-09 |
2023-06-07 |
V
Vente
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
2 538
-13.4%
88,04
223 446 USD
|
2 538
-13.4%
|
88,04
|
223 446 USD
|
|
|
2023-06-01 |
2023-05-30 |
V
Vente
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
2 304
-12.1%
83,33
191 992 USD
|
2 304
-12.1%
|
83,33
|
191 992 USD
|
|
|
2023-01-25 |
2023-01-23 |
VP
Vente planifiée
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
2 391
-12.2%
90,00
215 190 USD
|
2 391
-12.2%
|
90,00
|
215 190 USD
|
|
|
2022-10-26 |
2022-10-24 |
V
Vente
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
75
-0.5%
80,39
6 029 USD
|
75
-0.5%
|
80,39
|
6 029 USD
|
|
|
2022-10-26 |
2022-10-24 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
180
-0.6%
80,39
14 470 USD
|
180
-0.6%
|
80,39
|
14 470 USD
|
|
|
2022-09-21 |
2022-09-19 |
V
Vente
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
212
-1.6%
76,25
16 165 USD
|
212
-1.6%
|
76,25
|
16 165 USD
|
|
|
2022-09-21 |
2022-09-19 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
11 448
-26.0%
78,36
897 065 USD
|
11 448
-26.0%
|
78,36
|
897 065 USD
|
|
|
2022-09-19 |
2022-09-15 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
6 029
-14.6%
78,50
473 277 USD
|
6 029
-14.6%
|
78,50
|
473 277 USD
|
|
|
2022-09-19 |
2022-09-15 |
VP
Vente planifiée
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
27 769
-40.1%
77,76
2 159 317 USD
|
27 769
-40.1%
|
77,76
|
2 159 317 USD
|
|
|
2022-09-07 |
2022-09-06 |
V
Vente
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
101
-0.6%
73,78
7 452 USD
|
101
-0.6%
|
73,78
|
7 452 USD
|
|
|
2022-08-16 |
2022-08-15 |
V
Vente
|
KROLL MARK W
Administrateur non-exécutif
|
8 016
-33.1%
73,71
590 859 USD
|
8 016
-33.1%
|
73,71
|
590 859 USD
|
|
|
2022-07-06 |
2022-07-05 |
V
Vente
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
42
-0.3%
66,18
2 780 USD
|
42
-0.3%
|
66,18
|
2 780 USD
|
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
30
-0.2%
62,60
1 878 USD
|
30
-0.2%
|
62,60
|
1 878 USD
|
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
1 148
-0.5%
62,60
71 865 USD
|
1 148
-0.5%
|
62,60
|
71 865 USD
|
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
277
-0.7%
62,60
17 340 USD
|
277
-0.7%
|
62,60
|
17 340 USD
|
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
42
-0.9%
62,60
2 629 USD
|
42
-0.9%
|
62,60
|
2 629 USD
|
|
|
2022-06-06 |
2022-06-02 |
V
Vente
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
198
-1.5%
62,69
12 413 USD
|
198
-1.5%
|
62,69
|
12 413 USD
|
|
|
2022-06-06 |
2022-06-02 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
249
-5.3%
62,69
15 610 USD
|
249
-5.3%
|
62,69
|
15 610 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
134
-2.8%
59,10
7 919 USD
|
134
-2.8%
|
59,10
|
7 919 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
91
-0.7%
59,10
5 378 USD
|
91
-0.7%
|
59,10
|
5 378 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
1 384
-7.4%
59,10
81 794 USD
|
1 384
-7.4%
|
59,10
|
81 794 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
2 496
-1.1%
59,10
147 514 USD
|
2 496
-1.1%
|
59,10
|
147 514 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
1 084
-6.4%
59,10
64 064 USD
|
1 084
-6.4%
|
59,10
|
64 064 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
3 258
-7.4%
59,10
192 548 USD
|
3 258
-7.4%
|
59,10
|
192 548 USD
|
|
|
2022-05-23 |
2022-05-19 |
V
Vente
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
1 418
-7.6%
59,10
83 804 USD
|
1 418
-7.6%
|
59,10
|
83 804 USD
|
|
|
2022-05-18 |
2022-05-16 |
VP
Vente planifiée
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
832
-0.4%
56,10
46 675 USD
|
832
-0.4%
|
56,10
|
46 675 USD
|
|
|
2022-05-18 |
2022-05-16 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
50
-1.2%
56,10
2 805 USD
|
50
-1.2%
|
56,10
|
2 805 USD
|
|
|
2022-05-18 |
2022-05-16 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
196
-0.5%
56,10
10 996 USD
|
196
-0.5%
|
56,10
|
10 996 USD
|
|
|
2022-05-18 |
2022-05-16 |
VP
Vente planifiée
|
Miller Laurie A.
SVP, Human Resources
Dirigeant
|
31
-0.3%
56,10
1 739 USD
|
31
-0.3%
|
56,10
|
1 739 USD
|
|
|
2022-05-18 |
2022-05-16 |
V
Vente
|
Llorens Josep
EVP, Global Manufacturing
Dirigeant
|
107
-0.7%
56,10
6 003 USD
|
107
-0.7%
|
56,10
|
6 003 USD
|
|
|
2022-04-19 |
2022-04-18 |
V
Vente
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
189
-1.3%
56,55
10 688 USD
|
189
-1.3%
|
56,55
|
10 688 USD
|
|
|
2021-10-27 |
2021-10-25 |
V
Vente
|
Strong Stewart W
President, Global Hospital
Dirigeant
|
75
-0.6%
71,93
5 395 USD
|
75
-0.6%
|
71,93
|
5 395 USD
|
|
|
2021-10-27 |
2021-10-25 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
120
-0.3%
71,93
8 632 USD
|
120
-0.3%
|
71,93
|
8 632 USD
|
|
|
2021-06-16 |
2021-06-14 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
39
-1.0%
59,87
2 335 USD
|
39
-1.0%
|
59,87
|
2 335 USD
|
|
|
2021-06-16 |
2021-06-14 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
195
-0.5%
59,87
11 675 USD
|
195
-0.5%
|
59,87
|
11 675 USD
|
|
|
2021-06-16 |
2021-06-14 |
V
Vente
|
Burke William P. Mr.
EVP, Chief Financial Officer
Dirigeant
|
190
-0.5%
59,87
11 375 USD
|
190
-0.5%
|
59,87
|
11 375 USD
|
|
|
2021-06-09 |
2021-06-07 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
81
-1.9%
55,09
4 462 USD
|
81
-1.9%
|
55,09
|
4 462 USD
|
|
|
2021-06-09 |
2021-06-07 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
442
-1.1%
55,09
24 350 USD
|
442
-1.1%
|
55,09
|
24 350 USD
|
|
|
2021-06-09 |
2021-06-07 |
V
Vente
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
2 715
-1.4%
55,09
149 569 USD
|
2 715
-1.4%
|
55,09
|
149 569 USD
|
|
|
2021-06-09 |
2021-06-07 |
V
Vente
|
Scanlan Jacqueline
SVP, Global Human Resources
Dirigeant
|
195
-4.4%
55,09
10 743 USD
|
195
-4.4%
|
55,09
|
10 743 USD
|
|
|
2021-05-28 |
2021-05-26 |
V
Vente
|
KROLL MARK W
Administrateur non-exécutif
|
11 813
-39.0%
55,10
650 896 USD
|
11 813
-39.0%
|
55,10
|
650 896 USD
|
|
|
2021-05-20 |
2021-05-19 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
220
-0.6%
55,19
12 142 USD
|
220
-0.6%
|
55,19
|
12 142 USD
|
|
|
2021-05-20 |
2021-05-19 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
42
-1.7%
55,19
2 318 USD
|
42
-1.7%
|
55,19
|
2 318 USD
|
|
|
2021-05-20 |
2021-05-19 |
V
Vente
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
1 024
-0.5%
55,19
56 515 USD
|
1 024
-0.5%
|
55,19
|
56 515 USD
|
|
|
2021-05-20 |
2021-05-19 |
V
Vente
|
Burke William P. Mr.
EVP, Chief Financial Officer
Dirigeant
|
238
-0.7%
55,19
13 135 USD
|
238
-0.7%
|
55,19
|
13 135 USD
|
|
|
2021-05-18 |
2021-05-17 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
42
-2.8%
55,97
2 351 USD
|
42
-2.8%
|
55,97
|
2 351 USD
|
|
|
2021-05-18 |
2021-05-17 |
V
Vente
|
Llorens Josep
SVP, Global Manufacturing
Dirigeant
|
114
-2.7%
55,97
6 381 USD
|
114
-2.7%
|
55,97
|
6 381 USD
|
|
|
2021-05-18 |
2021-05-17 |
V
Vente
|
Burke William P. Mr.
EVP, Chief Financial Officer
Dirigeant
|
219
-1.9%
55,97
12 257 USD
|
219
-1.9%
|
55,97
|
12 257 USD
|
|
|
2021-05-18 |
2021-05-17 |
VP
Vente planifiée
|
Simon, Christopher
President & CEO
Administrateur exécutif
|
956
-0.6%
55,97
53 507 USD
|
956
-0.6%
|
55,97
|
53 507 USD
|
|
|
2021-04-20 |
2021-04-16 |
VP
Vente planifiée
|
Lingamneni Anila
EVP, Chief Technology Officer
Dirigeant
|
170
-4.7%
119,44
20 305 USD
|
170
-4.7%
|
119,44
|
20 305 USD
|
|
|
2021-03-10 |
2021-03-08 |
V
Vente
|
Basil Michelle L
EVP and General Counsel
Dirigeant
|
385
-2.4%
120,07
46 227 USD
|
385
-2.4%
|
120,07
|
46 227 USD
|
|
|
2021-03-10 |
2021-03-08 |
V
Vente
|
Scanlan Jacqueline
SVP, Global Human Resources
Dirigeant
|
107
-2.4%
120,07
12 847 USD
|
107
-2.4%
|
120,07
|
12 847 USD
|
|
|
2021-02-05 |
2021-02-04 |
V
Vente
|
Dockendorff Charles J
Administrateur non-exécutif
|
12 180
-47.0%
134,53
1 638 575 USD
|
12 180
-47.0%
|
134,53
|
1 638 575 USD
|
|
|
2021-02-05 |
2021-02-04 |
V
Vente
|
MEELIA RICHARD J
Administrateur non-exécutif
|
10 353
-24.4%
134,64
1 393 928 USD
|
10 353
-24.4%
|
134,64
|
1 393 928 USD
|
|
|
2021-02-05 |
2021-02-04 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
238
-13.6%
136,26
32 430 USD
|
238
-13.6%
|
136,26
|
32 430 USD
|
|
|
2021-02-05 |
2021-02-04 |
V
Vente
|
Goldstein Dan
VP, Corporate Controller
Dirigeant
|
500
-22.2%
135,72
67 860 USD
|
500
-22.2%
|
135,72
|
67 860 USD
|
|
